Survodutide na tirzepatide ni imiti yinjizwa mu mubiri ikomeje kwigwa kugira ngo igabanye ibiro n'ubuzima bwa metabolike. Ikindi kiruta ikindi ni uko tirzepatide yemewe na FDA kandi iboneka, mu gihe survodutide ikiri mu igeragezwa ry'abaganga kandi ntabwo iraboneka ku bantu. Nanone kandi zikoresha inzira zitandukanye za homoni, bishobora kuba ingenzi ku ntego zihariye z'ubuzima.
Niba urimo ugerekena uko izi nkingo ebyiri zihagaze, dore ibyo ubushakashatsi bugaragaza kugeza ubu.
Buri Muti Ukora Gute?
Zombi ni "dual agonists", bivuze ko zikoresha reseptor eshatu icyarimwe. Ariko, insanganyamatsiko zabo zitandukanye, kandi ibyo bigatandukanya uko zikora ku mubiri wawe.
Tirzepatide ikoresha reseptor za GLP-1 na GIP. GLP-1 (glucagon-like peptide-1) igabanya inzara, igabanya vuba kugenda kwa gikono, kandi ifasha kugenzura isukari mu maraso. GIP (glucose dependent insulinotropic polypeptide) yongera insuline isohoka kandi ishobora kugira ingaruka ku buryo umubiri wawe utunganya ibinure. Izi nzira ebyiri hamwe zihindura ubuzima bwawe mu buryo bukomeye ku kugenzura isukari mu maraso no kugabanya ibiro. Tirzepatide igurishwa munsi y'izina rya Mounjaro (ku bantu barwaye diyabete yo mu bwoko bwa 2) na Zepbound (ku bantu bashaka kugabanya ibiro).
Survodutide ikoresha reseptor za GLP-1 na glucagon. Ifite ubushobozi bwo kugabanya inzara bwa GLP-1 nk'ubwa tirzepatide, ariko aho kuba GIP, yongera inzira ya glucagon. Glucagon ifasha umubiri wawe kwongera ingufu zikoreshwa n'ikoreshwa ry'ibinure bibitswe, cyane cyane ibinure byo mu gitoke. Ibi bituma survodutide iryoheye cyane ku ndwara nko ku bantu barwaye MASH (metabolic dysfunction-associated steatohepatitis), indwara ikomeye y'ibitoke by'ibinure.
Rero, tirzepatide yibanda ku nzara hamwe na sisitemu ya insuline, mu gihe survodutide yibanda ku kugabanya inzara no gukoresha ingufu. Bombi biganisha ku kugabanya ibiro, ariko bakoresheje uburyo butandukanye buke.
Ibisubizo by'Ikigeragezo Cy'Ubugabanya Bw'Ibiro Byerekana Iki?
Hano niho abantu benshi bashaka igisubizo gisobanutse. Bishashyitse ku makuru yakusanyijwe mu bikigeragezo by'abaganga, tirzepatide ubu yerekana ko igabanya ibiro kuruta survodutide.
Inyigo nini yo mu 2022 y'abantu 2.539 yasanze ko tirzepatide ku rugero rwa 5 kugeza 15 mg yagabanije 15 kugeza 20.9 ku ijana by'ibiro nyuma y'ibyumweru 72. No k'umwaka wa 48, abitabiriye bari bafite ubunini bwa 14 kugeza 19 ku ijana. Bamwe mu bantu babikoresheje babitangaje ko bagabanyije hejuru ya 20 ku ijana by'ibiro byabo.
Igeragezwa ry'igihembwe cya 2 ku bantu barwaye umubyibuho rikoreshwa na survodutide ryari rigizwe n'abantu 387 kandi ryerekana ko hagabanutse ibiro ku 6.2 kugeza 14.9 ku ijana mu rugero rwo hejuru nyuma y'ibyumweru 46. Ingano y'ikigereranyo y'ibiro byagabanutseho 15 ku ijana irashimishije, ariko inyigo yari ngufi kandi nto ugereranijwe n'inyigo z'ingenzi za tirzepatide.
Birakenewe kumenya ko survodutide ikiri mu gihembwe cya 3 cy'igeragezwa. Inyigo nini kandi ndende cyane ishobora kugaragaza imibare itandukanye. Ariko bishingiye ku byo dufite uyu munsi, tirzepatide yerekana ko igabanya ibiro byinshi muri rusange.
Bite se ku Kugenzura Isukari mu Maraso?
Tirzepatide ifite amakuru akomeye hano. Inyigo zakorewe ku baganga zerekanye ko yagabanyije HbA1c (ikigereranyo cy'isukari mu maraso mu mezi atatu) kugeza ku bipimo 2.4 mu bantu barwaye diyabete yo mu bwoko bwa 2. Ibyo ni bimwe mu bigabanyijwe cyane biboneka ku muti ufungwa n'inkingo wa diyabete.
Survodutide na yo yerekanye ko yongereye isukari mu maraso mu gihembwe cya 2 cy'igeragezwa ry'abaganga babifite. Ariko, amakuru afite ni make kandi ibisohotse biracyemeza mu nyigo nini.
Ku bantu barwaye diyabete yo mu bwoko bwa 2 bashaka umuti ufite ikemezo ubu, tirzepatide ifite amakuru menshi.
Survodutide Ihagaze Hejuru?
Survodutide ifite akamaro kidasanzwe ku gukoresha reseptor ya glucagon, bishobora gutuma ihagira inyungu Tirzepatide itagira.
Ubuzima bw'umwijima. Mu gihembwe cya 2 cy'igeragezwa ku bantu barwaye MASH ihamye n'ubugumba bw'umwijima, 43 kugeza 62 ku ijana by'abafashe survodutide bagize icyo bikora ku murima w'umwijima nyuma y'ibyumweru 48, ugereranije na 14 ku ijana bafashe placebo. Hagati ya 34 kugeza 36 ku ijana byerekana ko habayeho kuzahura uburinganire bw'umwijima.
Gukoresha ingufu. Inzira ya Glucagon ishobora kongera metabolism ndetse n'igihe uri kuruhuka, bivuga ko umubiri wawe ukoresha calories nyinshi ndetse uri kuruhuka. Ibi ni uburyo butandukanye na tirzepatide, yibanda ku kugabanya ibyo utunye.
Survodutide yakiriye ibikoresho by'ingenzi bya FDA "Breakthrough Therapy" na "Fast Track", bivuga ko abaregura babona ko ari umuti ushobora kuba ingenzi ku ndwara zikomeye. Hafi ya mbere, hariho ibigeragezo by'igihembwe cya 3 mu bantu bafite umubyibuho cyane n'abafite MASH.
Uburyo Impfu Zihuzanyije?
Bombi bigaragarira mu ndwara zo mu gifu. Ibi ni ibisanzwe ku bwoko bwose bw'imiti ya GLP-1.
Ku tirzepatide, ibigaragara kenshi ni: kubabara mu nda, impiswi, kuruka, n'umuhogo. Mu bikigeragezo by'abaganga, hafi ya 4.3 kugeza 7.1 ku ijana by'abitabiriye baretse kuvura kubera ibibazo. Benshi mu bibazo by'igifu byari bifite ubukana buke kugeza ku bwicanya kandi bikagenda byorohera uko buhoro buhoro, cyane cyane iyo bishyirwamo gahoro gahoro.
Ku survodutide, ingano y'ibibazo irasa: kubabara mu nda, impiswi, kuruka, n'umuhogo. Ariko, mu gihembwe cya 2 cy'igeragezwa ry'abaganga babifite, 55 ku ijana by'abafashe survodutide bagaragaje ibibazo by'igifu ugereranije na 22 ku ijana bafashe placebo. Ubwinshi bw'ibirenga ku bibazo byaba bwinshi kuruta tirzepatide, nubwo amakuru ahuzanyije atarageza ubu.
Bombi bakeneye ko bagenda bashyiramo ku rugero ruto (gutangira hasi no kongera gahoro gahoro) kugira ngo bifashe umubiri kwihanganira kandi bikagabanya ibibazo by'igifu.
Icyo Ushobora Kubona Ubu Ni Iki?
Tirzepatide yemewe na FDA kandi iboneka ku ivuriro. Yinjizwa mu buryo bw'inkingo buri cyumweru ku rugero rwa 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, na 15 mg. Ubuvuzi bushobora kwishyurwa n'ubwishingizi mu gihe ufite diyabete yo mu bwoko bwa 2 cyangwa ubwoya bwo kugabanya ibiro.
Survodutide ntiyemewe cyangwa ngo iboneke hanze y'ibigeragezwa by'abaganga. Ntabwo hari gahunda yo kwemezwa kugeza ubu, kuko ibigeragezo by'igihembwe cya 3 birakomeje. Ntiwababona ku ivuriro cyangwa ku ibuye kugeza ubu.
Ibyingenzi
Tirzepatide ni umuti ufite ibimenyetso kandi iboneka, ufite amakuru akomeye ku kugabanya ibiro no kugenzura isukari mu maraso. Survodutide ni umuti mushya ushimishije ushobora gutanga inyungu zidasanzwe ku mwijima n'ibyo mu mubiri binyuze mu gukoresha glucagon. Niba ukeneye kuvurwa ubu, tirzepatide ni yo mahitamo meza. Niba ibisohotse mu gihembwe cya 3 cy'igeragezwa rikoreshwa na survodutide bivamo ibyiza byo mu ntangiriro, ishobora kuba umuti w'ingenzi mu gihe kizaza, cyane cyane ku bantu barwaye indwara y'umwijima w'ibinure.
